Wilm’s Tumor 1-guided preemptive treatment with hypomethylating agents for molecular relapse of AML and MDS after allogeneic transplantation
Christina Rautenberg, Anika Bergmann, Sabrina Pechtel, Carolin Fischermanns, Rainer Haas, Ulrich Germing, Guido Kobbe, Thomas Schroeder
Topics & Concepts
MedicineHypomethylating agentMinimal residual diseaseInternal medicineOncologyDonor lymphocyte infusionAzacitidineTransplantationComplete remissionMyeloid leukemiaDecitabineMyelodysplastic syndromesLeukemiaChemotherapyHematopoietic stem cell transplantationBone marrowBiochemistryDNA methylationGene expressionGeneChemistryAcute Myeloid Leukemia ResearchRenal and related cancersEpigenetics and DNA Methylation